MRD at the end of induction therapy in childhood acute lymphoblastic leukemia: outcome prediction strongly depends on the therapeutic regimen.
zur Stadt
U
U
Department of Pediatric Hematology and Oncology, University of Hamburg, Germany.
Harms
D O
DO
Schlüter
S
S
Schrappe
M
M
Goebel
U
U
Spaar
H
H
Janka
G
G
Kabisch
H
H
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002648:Child; D006801:Humans; D016130:Immunophenotyping; D018365:Neoplasm, Residual; D016133:Polymerase Chain Reaction; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy* / Q000235:genetics / Q000276:immunology / Q000473:pathology*; D011379:Prognosis; D016896:Treatment Outcome